Showing results (171-180 of 223) with videos related to
Sort By:
Pageof 23
Science Translational Medicine|January 9, 2015
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical studyMichael T Schweizer, Emmanuel S Antonarakis, Hao Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancerDana Rathkopf, Michael A Carducci, Michael J Morris, et al.Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.International Journal of Radiation Oncology, Biology, Physics|August 17, 2019
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins ExperienceMatthew P Deek, Colburn Yu, Ryan Phillips, et al.JCO Precision Oncology|October 26, 2019
Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical ProstatectomyPedro Isaacsson Velho, David Lim, Hao Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2017
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and EnzalutamideEmmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.European Urology|June 10, 2019
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate CancerPedro Isaacsson Velho, Wei Fu, Hao Wang, et al.The Oncologist|April 22, 2025
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomesYasaman Iranmanesh, Noha Omar, Arya Rasouli, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2024
Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome PredictionAndrei Gafita, Andrew Voter, Somya Shesadri, et al.Nature Reviews. Urology|November 1, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancerJoakin O Mori, Isra Elhussin, W Nathaniel Brennen, et al.Pageof 23